Synulox LC Plus Intramammary suspension for lactating cattle
Synulox LC Plus Intramammary suspension for lactating cattle
Authorised
- Prednisolone
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Synulox LC Plus Intramammary suspension for lactating cattle
Active substance:
- Prednisolone
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Cattle (dairy cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Prednisolone10.00/milligram(s)3.00gram(s)
-
Potassium clavulanate59.60/milligram(s)3.00gram(s)
-
Amoxicillin trihydrate229.60/milligram(s)3.00gram(s)
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (dairy cow)
-
Meat and offal7day
-
Milk84hour84 hours. With cows milked twice daily, milk for human consumption may only be taken the 7th milking after the last treatment. Where any other milking routine is followed, milk may be taken for human consumption only after the same period from the last treatment (e.g. with 3 times a day milking, milk may be taken for human consumption at the 11th milking).
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RV01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- (ID4) 900 gram(s): unspecified outer container with 300 Syringe (Low Density PolyEthylene) each with 3 gram(s)
- (ID3) 72 gram(s): unspecified outer container with 24 Syringe (Low Density PolyEthylene) each with 3 gram(s)
- (ID2) 36 gram(s): unspecified outer container with 12 Syringe (Low Density PolyEthylene) each with 3 gram(s)
- (ID1) 9 gram(s): Box (Cardboard) with 3 Syringe (Low Density PolyEthylene) each with 3 gram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
- V 087/17/08/1535
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0315/001
Concerned member states:
-
Belgium
-
Luxembourg
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 16/03/2023
How useful was this page?:
